High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 10, 2015, Pages 2894-2898

  Fuhren, J ^a   Voskuil, W S ^a   Boel, C H E ^a   Haas, P J A ^a   Hagen, F ^b   Meis, J F ^b,c   Kusters, J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE; CYTOCHROME P-450 CYP51A, ASPERGILLUS; CYTOCHROME P450; FUNGAL DNA; FUNGAL PROTEIN; MICROSATELLITE DNA;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; BRAIN ABSCESS; CHILD; CLONAL VARIATION; DNA ISOLATION; FEMALE; FUNGAL STRAIN; HIGH RISK PATIENT; HUMAN; INVASIVE ASPERGILLOSIS; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NONHUMAN; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; ASPERGILLOSIS; CROSS INFECTION; DRUG EFFECTS; GENETICS; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; PHYLOGENY; PRESCHOOL CHILD; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; AZOLES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CYTOCHROME P-450 ENZYME SYSTEM; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGAL PROTEINS; HUMANS; INCIDENCE; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR TYPING; PHYLOGENY; PREVALENCE; YOUNG ADULT;

EID: 84943777504     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv177     Document Type: Article

References (16)

1. Brown GD, Denning DW, Gow NA et al. Hidden killers: human fungal infections. Sci Transl Med 2012; 4: 165rv13.
2. Chowdhary A, Kathuria S, Xu J et al. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog 2013; 9: e1003633.
3. Snelders E, van der Lee HA, Kuijpers J et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5: e219.
4. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-15.
5. Chowdhary A, Sharma C, Hagen F et al. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms. Future Microbiol 2014; 9: 697-711.
6. de Smet AM, Kluytmans JA, Cooper BS et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360: 20-31.
7. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
8. Arendrup MC, Cuenca-Estrella M, Lass-Flörl C et al. EUCAST Definitive Document EDef 9.2: Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Conidia Forming Moulds. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_ files/AFST/Files/EUCAST-AFST_EDEF_9_2_Mould_testing_20140815.pdf.
9. EUCAST. Antifungal Agents: Breakpoint Tables for Interpretation of MICs, Version 7.0. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_ files/AFST/Antifungal_breakpoints_v_7.0.pdf.
10. Mellado E, Garcia-Effron G, Alcazar-Fuoli L et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 2007; 51: 1897-904.
11. de Valk HA, Meis JF, Curfs IM et al. Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J Clin Microbiol 2005; 43: 4112-20.
12. van der Linden JW, Snelders E, Kampinga GA et al. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg Infect Dis 2011; 17: 1846-54.
13. Klaassen CH, de Valk HA, Curfs-Breuker IM et al. Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands. J Antimicrob Chemother 2010; 65: 901-5.
14. Steinmann J, Hamprecht A, Vehreschild MJ et al. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. J Antimicrob Chemother 2015; 70: 1522-6.
15. Ahmad S, Joseph L, Hagen F et al. Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures. J Antimicrob Chemother 2015; 70: 412-5.
16. Camps SM, Rijs AJ, Klaassen CH et al. Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism. J Clin Microbiol 2012; 50: 2674-80.